Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Alliance Pharma Plc LSE:APH London Ordinary Share GB0031030819 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.40 0.64% 62.60 62.70 63.20 63.20 62.00 63.00 1,631,641 16:35:04
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 163.2 18.2 1.4 45.7 338

Alliance Pharma Share Discussion Threads

Showing 2251 to 2272 of 2425 messages
Chat Pages: 97  96  95  94  93  92  91  90  89  88  87  86  Older
DateSubjectAuthorDiscuss
16/12/2019
10:58
Following on from my previous Open Orphans (ORPH) post, Cathal Friel has delivered as promised with the all share merger with hVIVO (HVO). Seeing as HVO was trading at 30p at the start of the year, 2.47 ORPH shares for for each HVO share at 15.6p is great value. This follows partnerships with biopharma giant Ipsen Group and Venn’s deal with Carna Bioscience, and will leverage up and commercialise HVO’s sb through the Open Orphan health data platform.

At 5.6p this still values ORPH at just £14m - combine in HVO at £11m plus the preferred partnership agreements and ORPH is set for a big 2020

sunningdale1
27/11/2019
09:23
Of little or no relevance to company earnings-wasn't selling for several reasons so good to see decisive action by mgmt to allocate marketing monies elsewhere or take on another product from elsewhere.
cumnor
27/11/2019
08:55
maz

To some extent, the price move isn't really the issue. What makes me angry is the lack of clarity in the announcements. I rewrote an RNS for another AIM company and asked them if that was what they really meant. The news itself wasn't good but was transient so represented a buying opportunity. By the time they had finished spinning it it was impossible to understand and as a result the share price dropped like a brick.

These are supposed to be communications not advertorials.

marksp2011
27/11/2019
08:14
You may well have a point as it was marked lower on opening
mazarin
27/11/2019
07:33
Todays announcement that APH is returning Xonvea rights can only be considered long-term as a positive move in view of its slow take up, but I question the flurry of activity before it went public. It suggests some insiders have been acting to their advantage ahead of formal announcement . Time will tell
mazarin
27/11/2019
07:30
I see it as bad news, as it entails the opposite of success.
winnings1
27/11/2019
07:27
From the Results

Xonvea

Prescriptions for Xonvea, for the treatment of nausea and vomiting of pregnancy where conservative management has failed, continue to increase month on month although at a lower rate than originally anticipated. We remain fully committed to the brand and await the forthcoming updated guidelines from The Royal College of Obstetricians and Gynaecologists, which are expected early next year.

and from the RNS

As previously indicated, the uptake of Xonvea in the UK has been slower than the Group originally anticipated, in part due to the ongoing delay in the issuing of updated clinical guidelines. In addition, the competitive landscape for Xonvea in Europe has shifted, making an EU rollout less attractive for Alliance.


i guess "fully committed" means something else to APH than it does to me.

marksp2011
26/11/2019
18:12
Very strong auction tonight.
Looks like someone is building but there isn't enough liuidity to do it in the trading day.
Also means someone was happy to offload.

marksp2011
25/11/2019
15:57
Cisk

Go for it
Always interested in new ideas on slow news days
If you want to ramp please provide the buy/sell justification it will make it worth reading.

marksp2011
25/11/2019
15:02
Winnings, thanks for that.

When I have something related to Alliance to add, I’ll be sure to do so.

Otherwise I’ll Keep quiet, which is what you should do also, unless you want to add something about Alliance.

Or maybe I’ll discuss other pharma stocks I own, or want to ramp, just for the hell of it.

cisk
25/11/2019
11:45
High time we hear more about the official investigation into APH's connection with the 'price-rigging' company that bought the full rights to one of APH's medicines.
I am not buying until I see the results of that investigation.

winnings1
25/11/2019
10:30
Cisk,

Sorry, we couldn't wait for you to post again.

Please feel free to contribute without mentioning your trades at 5p/10p as that didn't really add a lot for the rest of us.

marksp2011
25/11/2019
04:09
Guys I thought this was a board on Alliance. Please if you want to continue to discuss other stocks best place is the board for that stock...
cisk
24/11/2019
17:44
Just checked, plenty trades in the shares on the Bangladesh stock market and the share price there currently above 73 pence. I am happy holding my shares for the long term.
EPS growing, cash Dividends growing, Share Price jolly low, PE-Ratio jolly low, what's not to like.

winnings1
24/11/2019
17:13
Winnings

If you read the depreciation policies it is no wonder the number is so low. Not depreciating production assets would tend to oversate "profits"

Must admit I pay no attention at all to EPS, i stick with free cash flow, ROCE following the doctrines of Buffett, terry Smith and the like. EPS can be readily manipulated and is especially when there are management bonuses tied to it.

marksp2011
24/11/2019
17:05
Marksp2011 - First, my eggs are in many bsskets and on the whole my spread of investments has outperformed many a unit trust. Second, I focus on EPS growth, and in that BXP scores very well. Third, I do like medicine/healthcare orientaded companies as I feel they are recession-resistant if not recession proof.
Fourth, I expect companies in low wage economies to outperform.
To sum up, I expect BXP to deliver me a good return.
P.S. Translated into Pound Sterlng the entertainment figure does not look so very high at about £80k. The depreciation figure in that same light looks jolly low at about £70k, almost unbelievably low.

winnings1
24/11/2019
14:05
Hi winnings

Whatever you think is good for you. I have read the accounts as best I can given the difference in accounting standards. I must admit that I have never seen an industrial company that has a bigger entertainment spend than the depreciation number.

I happen to think there are loads of ways of losing money without buying shares in a family managed bangladeshi company that averages 5 trades a day.

You put it out there for which I thank you. We have a very different view of what makes a good investment

marksp2011
24/11/2019
09:32
Marksp2011 / Investors/researchers residing in Bangladesh do not seem to share your concerns, the share price there is well above the share price here. As far as I can see BXP is a standalone company commercially linked to a distribution company with the latter operated by a related party - this link seems very successful/fruitful, bringing a constant flow of new outlets.
winnings1
18/11/2019
11:29
I wonder why the spread quote is so wide. MMs killed the trading early doors.
marksp2011
13/11/2019
12:42
Further to my last message, BXP'# share price on the Dhaka stock exchange is substantially higher than the trading price here. Clearly investors based in Bangladesh do like the shares and have the fullest confidence in the direction the Company is going. There is no indication of BXP being part of a larger concern, BXP stands on its own and conforms to the Dhaka Stock Exchange Rules, which are certainly no slack. I hold BXP long term, and plan to buy more.
winnings1
13/11/2019
11:19
Good Luck :)
marksp2011
13/11/2019
10:26
I have confidence in management, I have confidence in the Company's progress,
I have confidence in the listing on the Dhaka exchange, I have admiration for
the achievements, and the competitive edge of a company operating in a low wage
environment/county.

winnings1
Chat Pages: 97  96  95  94  93  92  91  90  89  88  87  86  Older
Your Recent History
LSE
APH
Alliance P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230127 03:57:31